Correlation between ACT anD APTT during Transcatheter Aortic Valve Implantation and Chronic Total Occlusion Percutaneous Coronary Interventions

Correlation between ACT anD APTT during Transcatheter Aortic Valve Implantation and Chronic Total Occlusion Percutaneous Coronary Interventions - ADAPT TAVI & CTO PCI

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49477

Enrollment

200

Registered

2020-09-10

Start date

2021-07-21

Completion date

Unknown

Last updated

2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic valve stenosis Chronic total Occlusion

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients accepted for a TAVI procedure to replace the aortic valve. Patients accepted for PCI procedure of their chronic total occlusion

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The main clinical study endpoints are any bleeding complication within 24 hours after the TAVI or CTO PCI procedure. For Cohort A the VARC2 document is used to determine the presence and severity of vascular and bleeding complications. For Cohort B the BARC criteria are used. protocol page 17	—

Countries

Netherlands

Outcome results